Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women

Farzana Kapadia, David Vlahov, Yingfeng Wu, Mardge H. Cohen, Ruth M. Greenblatt, Andrea A. Howard, Judith A. Cook, Lakshmi Goparaju, Elizabeth Golub, Jean Richardson, Tracey E. Wilson

Research output: Contribution to journalArticle

Abstract

Methadone maintenance is associated with improved adherence to antiretroviral therapies among HIV-positive illicit drug users; however, little information exists on whether adherence is associated with different drug abuse treatment modalities. Using longitudinal data from the Women's Interagency HIV Study, we evaluated the relationship between drug abuse treatment modality and adherence to antiretroviral therapies. In prospective analyses, individuals who reported accessing any drug abuse treatment program were more likely to report adherence to antiretroviral regimens ≥ 95% of the time (AOR = 1.39, 95% CI = 1.01-1.92). Involvement in either a medication-based or medication-free program was similarly associated with improved adherence. Drug abuse treatment programs, irrespective of modality, are associated with improved adherence to antiretroviral therapies among drug users. Concerted efforts to enroll individuals with drug use histories in treatment programs are warranted to improve HIV disease outcomes.

Original languageEnglish (US)
Pages (from-to)161-170
Number of pages10
JournalAmerican Journal of Drug and Alcohol Abuse
Volume34
Issue number2
DOIs
StatePublished - Mar 1 2008

    Fingerprint

Keywords

  • Adherence
  • Antiretroviral therapy
  • Drug abuse treatment modality
  • Human immunodeficiency virus

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Kapadia, F., Vlahov, D., Wu, Y., Cohen, M. H., Greenblatt, R. M., Howard, A. A., Cook, J. A., Goparaju, L., Golub, E., Richardson, J., & Wilson, T. E. (2008). Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. American Journal of Drug and Alcohol Abuse, 34(2), 161-170. https://doi.org/10.1080/00952990701877052